Kairos Pharma (KAPA) Q4 2024 Earnings
KAPA·Reported February 26, 2025·Before market open
Diluted EPS came in at $-0.09, missed the $-0.06 consensus by $0.03.
Diluted EPS
$-0.09missed by $0.03
Consensus: $-0.06
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about Kairos Pharma's Q4 2024 earnings report.
Kairos Pharma (KAPA) reported Q4 2024 earnings on February 26, 2025 before market open.
Kairos Pharma reported diluted EPS of $-0.09 for Q4 2024.
EPS missed the consensus estimate of $-0.06 by $0.03.